Nonsteroidal Anti-Inflammatory Drugs and the Kidney
Citations Over TimeTop 12% of 2010 papers
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the isoenzymes COX-1 and COX-2 of cyclooxygenase (COX). Renal side effects (e.g., kidney function, fluid and urinary electrolyte excretion) vary with the extent of COX-2-COX-1 selectivity and the administered dose of these compounds. While young healthy subjects will rarely experience adverse renal effects with the use of NSAIDs, elderly patients and those with co-morbibity (e.g., congestive heart failure, liver cirrhosis or chronic kidney disease) and drug combinations (e.g., renin-angiotensin blockers, diuretics plus NSAIDs) may develop acute renal failure. This review summarizes our present knowledge how traditional NSAIDs and selective COX-2 inhibitors may affect the kidney under various experimental and clinical conditions, and how these drugs may influence renal inflammation, water transport, sodium and potassium balance and how renal dysfunction or hypertension may result.
Related Papers
- → Blood and Plasma 5–Hydroxytryptamine Levels in Patients With Cirrhosis(1994)45 cited
- Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma.(1992)
- → Tomoxiprole Selectively Inhibits Cyclooxygenase-2(1997)4 cited
- The Relationship between Serum Nitric Oxide and Hypoxemia of Liver Cirrhosis(2000)
- Analysis on Clinical Characteristics of Primary Hepatocellular Carcinoma with or Without Cirrhosis(2003)